Abstract
Development of Novel S-N3-DABOs Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency and Selectivity
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have